Surgery Partners Stock Target Price and Analyst Consensus
| SGRY Stock | USD 23.60 0.01 0.04% |
The current analyst and expert consensus on Surgery Partners is Strong Buy, with 8 strong buy opinions. The current projected Surgery Partners target price consensus is 33.52 with 13 analyst opinions. Check out Macroaxis Advice on Surgery Partners to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.The most common way Surgery Partners analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Surgery Partners executives and customers to further validate their buy or sell advice. Surgery Partners buy-or-sell recommendation module provides average expert sentiment on the projected Surgery Partners target price to derive its highest and lowest estimates based on projected price volatility of 3.4266.
Lowest Forecast 30.5 | Highest Forecast 37.21 | Target Price 33.52 |
Surgery |
It's important to approach Surgery Partners' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Surgery Partners Target Price Consensus
Surgery target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Surgery Partners' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 13 | Strong Buy |
Most Surgery analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Surgery stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Surgery Partners, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSurgery Partners Target Price Projection
Surgery Partners' current and average target prices are 23.60 and 33.52, respectively. The current price of Surgery Partners is the price at which Surgery Partners is currently trading. On the other hand, Surgery Partners' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Surgery Partners Market Quote on 16th of March 2025
Target Price
Analyst Consensus On Surgery Partners Target Price
Surgery Partners Analyst Ratings
Surgery Partners' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Surgery Partners stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Surgery Partners' financials, market performance, and future outlook by experienced professionals. Surgery Partners' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Surgery Partners price targets
Surgery Partners' stock target price is an estimate of its future price, usually made by analysts. Using Surgery Partners' target price to determine if it is a suitable investment can be done through the following steps:- Look at Surgery Partners' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Surgery Partners' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Surgery Partners Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Surgery Partners is a key component of Surgery Partners valuation and have some predictive power on the future returns of a Surgery Partners.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Momentum Invested few shares | |
 | Cash Cows Invested few shares | |
 | Dividend Beast Invested over 60 shares | |
 | SRI Sustainable Growth Invested over 40 shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Macroaxis Index Sold over 90 shares | |
 | Utilities Invested over 90 shares | |
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.